Direkt zum Inhalt
Merck

Fortfahren mit

SAE0110

HRV-3C Protease, Biotin tagged

Recombinant protein, 0.8-1.2 mg/mL, aqueous solution

Synonym(e):

Human Rhinovirus 3C Protease, Levlfqgp site protease, PreScission Protease

Anmelden zur Ansicht der Organisations- und Vertragspreise.

Größe auswählen

Ansicht ändern
Größe/SKUVerfügbarkeitPreis
0.5 mg
Warenkorb auf Verfügbarkeit prüfen
€ 271,00

Über diesen Artikel

NACRES:
NA.54
UNSPSC Code:
12352202
eCl@ss:
32035490
Specific activity:
≥5000 U/mg
Assay:
≥90%
Biological source:
human (human Rhinovirus Type 14)
Recombinant:
expressed in E. coli
Concentration:
0.8-1.2 mg/mL

€ 271,00


Warenkorb auf Verfügbarkeit prüfen

​
Sonderanfertigung anfragen
Technischer Dienst
Benötigen Sie Hilfe? Unser Team von erfahrenen Wissenschaftlern ist für Sie da.
Unterstützung erhalten


biological source

human (human Rhinovirus Type 14)

recombinant

expressed in E. coli

assay

≥90%

form

aqueous solution

specific activity

≥5000 U/mg

mol wt

22 kDa

concentration

0.8-1.2 mg/mL

technique(s)

protein purification: suitable

optimum pH

7.5

suitability

suitable for protein modification

application(s)

life science and biopharma

shipped in

dry ice

storage temp.

−20°C

General description

Substrate Specificity

Selective cleavage of Gln-|-Gly bond in the poliovirus polyprotein. In other picornavirus reactions Glu may be substituted for Gln, and Ser or Thr for Gly
HRV-3C protease from human rhinovirus type 14 is a protease that specifically cleaves within an eight-residue recognition sequence.This sequence is: Leu-Glu-Val-Leu-Phe-Gln-Gly-Pro.Proteolytic cleavage occurs between the Gln and Gly residues. The HRV-3C protease is useful for cleaving recombinant proteins that are expressed as fusion proteins with this sequence between the carrier domain and the protein of interest.
This biotinylated HRV-3C protease is intended for on-column cleavage of fusion proteins with an HRV-3C cleavage site. It specifically cleaves the protein of interest from a column-bound fusion protein, leaving the fusion domain or tag bound to the affinity column (e.g. Ni-NTA column) and eluting only the protein of interest. This method is advantageous over post-elution cleavage for several reasons:
  • It eliminates most impurities normally associated with purification on Ni-chelating columns.
  • It allows gentler elution conditions, with added flexibility in the elution buffer composition. This can mitigate protein aggregation and inactivation.

After cleavage, the protease can be removed with any avidin-conjugated or streptavidin-conjugated beads. This product has been enzymatically biotinylated with no effect on its proteolytic activity. It has no additional protein purification tags. The product is supplied in aqueous buffer (0.8–1.2 mg/mL) with 20 mM Trizma®-HCl, pH 8.0, 200 mM NaCl, 1 mM TCEP, and 50% (v/v) glycerol.

Preparation Note

The product is supplied in aqueous buffer (0.8–1.2 mg/mL) containing 20 mM Trizma®-HCl, pH 8.0, 200 mM NaCl, 1 mM TCEP, and 50% (v/v) glycerol.

Legal Information

Trizma is a registered trademark of Merck KGaA, Darmstadt, Germany

Ähnliche Artikel vergleichen

Vollständigen Vergleich anzeigen

Unterschiede anzeigen

1 of 1

Dieser Artikel
SAE004571493MM71493M
description

Recombinant protein, 0.8-1.2 mg/mL, aqueous solution

description

N-Terminal His tagged recombinant protein, aqueous solution, 0.8-1.2 mg/mL

description

Highly efficient fusion tag removal at low temperature

description

Highly efficient fusion tag removal at low temperature

assay

≥90%

assay

≥90% (SDS-PAGE)

assay

-

assay

-

biological source

human (human Rhinovirus Type 14)

biological source

human (human Rhinovirus Type 14)

biological source

-

biological source

-

technique(s)

protein purification: suitable

technique(s)

protein purification: suitable

technique(s)

-

technique(s)

-

specific activity

≥5000 U/mg

specific activity

≥5000 U/mg

specific activity

-

specific activity

-

concentration

0.8-1.2 mg/mL

concentration

0.8-1.2 mg/mL

concentration

-

concentration

1.8-3.0 unit/μL

application(s)

life science and biopharma

application(s)

life science and biopharma

application(s)

-

application(s)

-


Lagerklasse

10 - Combustible liquids

WGK

WGK 2

Flammpunkt (°F)

Not applicable

Flammpunkt (°C)

Not applicable



Hier finden Sie alle aktuellen Versionen:

Analysenzertifikate (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Dokumente section.

Wenn Sie Hilfe benötigen, wenden Sie sich bitte an Kundensupport

Besitzen Sie dieses Produkt bereits?

In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.

Die Dokumentenbibliothek aufrufen




Questions

Reviews

No rating value

Active Filters